|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu ff"
Showing items 1-8 of 8 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國家衛生研究院 |
2022-09-12 |
A critical overview of current progress for COVID-19: Development of vaccines, antiviral drugs, and therapeutic antibodies
|
Kumari, M;Lu, RM;Li, MC;Huang, JL;Hsu, FF;Ko, SH;Ke, FY;Su, SC;Liang, KH;Yuan, JPY;Chiang, HL;Sun, CP;Lee, IJ;Li, WS;Hsieh, HP;Tao, MH;Wu, HC |
| 國家衛生研究院 |
2020-01 |
Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
|
Huang, KW;Hsu, FF;Qiu, JTT;Chern, GJ;Lee, YA;Chang, CC;Huang, YT;Sung, YC;Chiang, CC;Huang, RL;Lin, CC;Dinh, TK;Huang, HC;Shih, YC;Alson, D;Lin, CY;Lin, YC;Chang, PC;Lin, SY;Chen, YC |
| 國家衛生研究院 |
2019-11-18 |
Delivery of nitric oxide with a nanocarrier promotes tumour vessel normalization and potentiates anti-cancer therapies
|
Sung, YC;Jin, PR;Chu, LA;Hsu, FF;Wang, MR;Chang, CC;Chiou, SJ;Qiu, JT;Gao, DY;Lin, CC;Chen, YS;Hsu, YC;Wang, J;Wang, FN;Yu, PL;Chiang, AS;Wu, AY;Ko, JJ;Lai, CP;Lu, TT;Chen, YC |
| 國家衛生研究院 |
2018-01-23 |
Identification of danthron as an isoform-specific inhibitor of HEME OXYGENASE-1/cytochrome P450 reductase interaction with anti-tumor activity
|
Chou, YT;Hsu, FF;Hu, DY;Chen, YC;Hsu, YH;Hsu, JT;Chau, LY |
| 高雄醫學大學 |
2012 |
葛根湯在呼吸道細胞株抑制人類呼吸道融合病毒
|
張榮叁;王國治;謝登恩;許芬芳;蔣連財 ; Chang JS;Wang KC;Shieh DE;Hsu FF;Chiang LC |
| 臺北醫學大學 |
2006 |
Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.
|
許重義; Yan P; Hu X; Song H; Yin K; Bateman RJ; Cirrito JR; Xiao Q; Hsu FF; Turk JW; Xu J; Hsu CY |
| 臺北醫學大學 |
2006 |
Matrix metalloproteinases expressed by astrocytes mediate extracellular A-beta catabolism.
|
許重義; Yin KJ; Cirrito JR; Yan P; Hu X; Xiao Q; Pan X; Bateman R; Song H; Hsu FF; Turk J; Xu J; Hs |
| 高雄醫學大學 |
2004 |
山茱萸預防肝癌
|
張榮參;蔣連財;許芬芳;林俊清 ; Chang JS;Chiang LC;Hsu FF;Lin CC |
Showing items 1-8 of 8 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
